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Background. EntropyTM is an anaesthetic EEG monitoring method, calculating two numerical
parameters: State Entropy (SE, range 0–91) and Response Entropy (RE, range 0–100). Low
Entropy numbers indicate unconsciousness. SE uses the frequency range 0.8–32 Hz, represent-
ing predominantly the EEG activity. RE is calculated at 0.8–47 Hz, consisting of both EEG and
facial EMG. RE–SE difference (RE2SE) can indicate EMG, reﬂecting nociception. We studied
RE2SE and EMG in patients anaesthetized without neuromuscular blockers.
Methods. Thirty-one women were studied in propofol–nitrous oxide (P) or propofol–nitrous
oxide–remifentanil (PR) anaesthesia. Target SE value was 40–60. RE2SE was measured before
and after endotracheal intubation, and before and after the commencement of surgery. The spec-
tral content of the signal was analysed off-line. Appearance of EMG on EEG was veriﬁed visually.
Results. RE, SE, and RE2SE increased during intubation in both groups. Elevated RE was fol-
lowed by increased SE values in most cases. In these patients, spectral analysis of the signal
revealed increased activity starting from low (,20 Hz) frequency area up to the highest measured
frequencies. This was associated with appearance of EMG in raw signal. No spectral alterations
or EMG were seen in patients with stable Entropy values.
Conclusions. Increased RE is followed by increased SE at nociceptive stimuli in patients not
receiving neuromuscular blockers. Owing to their overlapping power spectra, the contribution of
EMG and EEG cannot be accurately separated with frequency analysis in the range of 10–40 Hz.
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EEG is the method of choice in measuring the hypnotic
component of anaesthesia. During the last decade, several
measures have been introduced for this purpose. The most
widely adopted EEG measure of anaesthetic drug effect is
Bispectral Index (BISTM monitor, Aspect Medical Systems,
Newton, MA, USA).
1 BIS utilizes a sensor placed in the
forehead and temple of the patient to collect EEG. Although
the approach is easy to use for anaesthetists, the placement
is prone to facial EMG contamination,
2 which is shown to
represent impending arousal or nociception,
3 even during
deep hypnosis with propofol.
4 Therefore, a single-number
index like BIS can never tell with certainty the impact of
EMG on the information received from the analysed signal.
To at least partly overcome the problem described above,
another EEG monitoring device, the M-ENTROPYTM
module (GE Healthcare, Helsinki, Finland), was introduced.
5
The M-ENTROPYTM module calculates the characteristics of
the upper facial biosignal with an analysis of time–frequency
balanced spectral entropy, taking into account the special
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of EEG and EMG activity is called Entropy, which has been
shown to be a valid indicator of the hypnotic effect of
propofol, thiopental, isoﬂurane, sevoﬂurane, and desﬂurane.
6
Entropy consists of two parameters: State Entropy (SE)
and Response Entropy (RE). SE is computed over the
frequency range from 0.8 to 32 Hz, which represents the
EEG-dominant part of the frequency spectrum. Therefore,
SE reﬂects the cortical state of the patient. RE is computed
over the frequency range from 0.8 to 47 Hz, covering both
the EEG-dominant and the EMG-dominant areas of the
spectrum. Consequently, RE2SE difference serves at least
partly as an indicator of upper facial EMG activation.
5
The RE and SE are both calculated with 5s intervals
from the preceding 1.92 and 15 s segments of EEG,
respectively, and the new values are shown on the screen
and output from the monitor.
The appearance of upper facial EMG indicates that the
patient is responding to an external stimulus,
7 which is
usually nociceptive. Therefore, RE2SE difference may
indicate nociception or inadequate anaesthesia, an assump-
tion supported by one recently published article,
8 but
disputed by another.
9
The present study was designed to prospectively investi-
gate RE, SE, RE2SE difference, and upper facial EMG
during propofol–nitrous oxide or propofol–nitrous oxide–
remifentanil anaesthesia in patients without neuromuscular
blocking agent (NMBA) medication (i) before and after
intubation and (ii) before and after beginning of laparo-
scopic surgery. The primary aim of the study was to evalu-
ate the behaviour of RE, SE, and RE2SE difference
between the groups. Secondary aims were to compare the
Entropy indices between intubation and surgery, to study
the impact of visually veriﬁed EMG on the indices, and to
make comparisons between heart rate (HR) and RE2SE
difference. As remifentanil is a very potent opioid, we
hypothesized that smaller increase in RE, and therefore,
smaller RE2SE difference would be seen in patients
receiving remifentanil as an adjuvant of their propofol2
nitrous oxide anaesthesia. We also hypothesized that EMG
would react more precisely than EEG to nociceptive
stimuli, and that changes of RE2SE difference would
associate with alterations in HR. To our knowledge, this is
the ﬁrst clinical study where the appearance of EMG is
veriﬁed visually both from the original biosignal and from
its spectral presentation, and compared with the behaviour
of the Entropy parameters.
Methods
Patients
This study followed the design of a prospective clinical
study. The local Ethics Committee and Finnish National
Agency for Medicines approved the study protocol. All
patients gave their written informed consent. Inclusion
criteria were the following: patients undergoing elective
laparoscopic gynaecological surgery (expected duration
.30 min) between ages 18 and 60 yr, and ASA physical
status I or II. Patients were excluded if they had a disease
or injury affecting the central nervous system, alcohol or
drug abuse, or BMI .28. All patients fasted overnight
before surgery. A total of 33 patients were enrolled.
Electroencephalogram acquisition
The forehead biosignal was collected with a disposable
electrode strip (Entropy Sensor, GE Healthcare) for
Entropy measurement. After degreasing of the forehead
skin using isopropanol 70%, the strip was positioned as
recommended by the manufacturer. The signal was
acquired from two electrodes of the strip: one frontally in
the midline, 2 cm above the eyebrows, and the other 2 cm
laterally from the outer canthus of the left eye. The ﬁrst
electrode is on the frontal muscle, the second on the orbi-
cularis oculi and temporal muscles. Entropy was collected
with an M-ENTROPYTM module of the S/5TM Anesthesia
Monitor (GE Healthcare). The sampling rate was 400 Hz.
High- and low-pass ﬁlters of 0.5 and 118 Hz (23 dB;
10 dB per decade), respectively, were applied. Power line
artifact was not ﬁltered. All the monitored values were
collected on a laptop computer.
Anaesthesia and study protocol
RE, SE, and vital signs were collected under two anaes-
thetic regimens, both of which included premedication
with diazepam 10 mg p.o. An i.v. route was established for
all patients and an infusion of isotonic saline was started.
Intermittent non-invasive arterial pressure was recorded
every 5min. Electrocardiogram, inspired fractions and
end-tidal concentrations of anaesthetic gases and CO2, and
peripheral oxygen saturation were continuously monitored
with the Datex-Ohmeda S/5TM Anesthesia Monitor.
Entropy monitoring started before induction of anaes-
thesia and continued uninterrupted until the end of the
study. Seventeen patients were anaesthetized with propofol
3m gk g
21 i.v., followed by manually controlled venti-
lation of nitrous oxide 67% in oxygen via face mask.
Endotracheal intubation was performed, as gently as
possible, 150 s later. If intubation difﬁculties were met,
mask ventilation was re-started and another intubation
attempt was done 1–3 min later. If the second attempt was
unsuccessful, rocuronium was given and the patient was
discarded from the study. After securing the airway, con-
trolled mechanical ventilation was started with a fresh ﬂow
of 6 litre min
21 (67% nitrous oxide in oxygen), and propo-
fol infusion was started. The infusion rate of propofol was
adjusted to keep the Entropy parameters between 40 and
60, the target being 50.
Sixteen patients were anaesthetized the same way as
described above, but target-controlled infusion (TCI,
Aho et al.
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of remifentanil was added to the anaesthetic regimen.
Remifentanil was infused with the estimated effect-site
concentration (Ce) of 4.0 ng ml
21 from the beginning of
anaesthetic induction (the pharmacokinetic model of Minto
and colleagues)
10 until the end of the study. Laryngoscopy
for endotracheal intubation was initiated after reaching the
remifentanil Ce of 4.0 ng ml
21.
After endotracheal intubation, patients were not touched
or otherwise disturbed for 5 min to discover the magnitude
of RE2SE difference, and the presence or absence of
EMG, during anaesthesia without surgery. After 5 min, the
patient was prepared for operation and permission to start
laparoscopy was granted. A propofol bolus of 50 mg was
given as a rescue medication if the Entropy values
exceeded 60, and repeated 90 s later, if needed. The study
was completed 1 min after setting the ﬁrst laparoscopy
trochar. Thereafter, the administration of nitrous oxide was
discontinued and patient’s lungs were ventilated with air/
oxygen. Fentanyl (the propofol group) and rocuronium
were given according to clinical needs.
Analyses of the biosignal
RE and SE values were analysed off-line as a mean of 15
s (three consecutive readings) at the following time points:
awake, 90 s after anaesthetic induction, 30 s before intuba-
tion, 30 s after intubation, after a 5 min equilibrium period,
60s before skin incision, 30 s after skin incision, 30 s after
setting of the needle of Veress, 30 s after beginning of gas
insufﬂation, at the end of gas insufﬂation, and 30 s after
setting of the ﬁrst laparoscopy trochar. RE2SE was calcu-
lated by subtracting the SE value from the corresponding
RE value.
Spectrogram, that is, a presentation of the spectral
content of a biosignal, was produced with SomnologicaTM
sleep analysis program (Medcare Flaga, Reykjavik,
Iceland). Power spectra of consecutive 1.0 s samples of the
signal are calculated and presented vertically along y-axis,
plotted against time in x-axis. The density (i.e. ‘darkness’)
of spectrogram reveals the amount of activity at respective
frequency. Thus, spectrogram presents the same infor-
mation as successive power spectra, but in a compressed
form. Power line artifact is seen in spectrogram as a sharp
activity band at 50 or 60 Hz, and ECG or EOG artifacts
are typically located at rather low frequency range.
Therefore, EMG is virtually the only artifact that is dis-
played over a wide frequency range.
Both the raw biosignal and a spectrogram at the time
points of interest were inspected visually off-line, without
knowledge of the behaviour of the Entropy indices, by an
experienced clinical neurophysiologist (V.J.), to judge the
presence or absence of EMG. Later on, the traces and classi-
ﬁcations were analysed jointly by all authors, to ensure the
agreement of the detections. To demonstrate the effect of
EMG on the EEG spectrum, spectral analyses before and
after intubation or commencement of surgery were drawn in
four patients. In analyses, a window of 15 s was used.
All patients were interviewed during the ﬁrst postoperative
day, regarding their possible anaesthesia and surgery-related
memories and intubation-associated sequelae.
Statistical methods
The study was designed to have a power of 80% to detect
statistical signiﬁcance, assuming two-sided a-level of
0.05, with surgery-associated mean RE2SE differences of
7.0 and 2.0 units (SD 4.5 units) between the propofol and
the propofol2remifentanil groups, respectively. The power
calculation was based on the previous unpublished
Entropy data of our own. To meet the criteria of power
calculation, 14 patients per group were needed. All statisti-
cal analyses were performed using SPSS for Windows soft-
ware (version 16.0, SPSS, Chicago, IL, USA). One-way
analysis of variance followed by t-tests was used for para-
metric data, and Mann–Whitney and x
2 tests were used for
non-parametric comparisons, where appropriate. Pearson’s
correlation analysis was used to compare the change of HR
with that of RE2SE difference at endotracheal intubation.
P,0.05 was considered statistically signiﬁcant.
Results
Two enrolled patients, both receiving propofol2nitrous
oxide without remifentanil, were excluded because of
problems in laryngoscopy and intubation. All others were
successfully intubated with one or two attempts. Therefore,
15 patients in the propofol2nitrous oxide group and 16
patients in the propofol2nitrous oxide2remifentanil group
were studied. Patient characteristics did not differ between
the groups. The mean ages of patients not receiving remi-
fentanil and those with remifentanil were 39vs 32yr, mean
weight was 62 vs 61 kg, and mean height was 166 vs
165 cm, respectively.
The RE or SE values did not differ between the groups
along the study. The RE2SE difference showed signiﬁcant
between-group difference awake and from skin incision to
the end of the study. Awake, the mean of propofol2nitrous
oxide group was 1.22 units higher (P,0.042). Therefore,
the groups were baseline-corrected by subtracting 1.22
units from all means in the propofol2nitrous oxide group.
After such correction, the only detected between-group
difference was after setting the ﬁrst laparoscopy trochar.
The behaviour of RE, SE, baseline-corrected RE2SE
difference, and HR in both groups is presented in Figure 1.
The SE and RE values increased more commonly after
intubation than after skin incision (Table 1). RE increased
 10 units in 27 events. This increase in RE values was
rapidly followed by  10 units increase of SE in 21/27
cases, thereby decreasing the calculated RE2SE
difference.
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229When all blindly analysed episodes of interventions
were pooled together, the EMG was present more fre-
quently in recordings of patients in the propofol group (79
EMG ﬁndings in 165 episodes) than in the propofol–
remifentanil group (33 ﬁndings in 176 episodes).
Incidence of EMG in both groups and the association
between EMG and Entropy RE2SE difference are given
in Table 2. In some patients, EMG changed the power
spectrum of the biosignal from 15 Hz up to  150 Hz, that
is, to the highest detectable frequencies. The presence of
EMG in the raw biosignal of an example patient, and its
effect on power spectrum, Entropy values, and spectro-
gram, is depicted in Figure 2.
Figure 3 presents the spectrograms from the whole
study period in two patients, one in the propofol group
and another in the propofol2remifentanil group. In some
patients, the EMG was seen on the top of suppressed EEG
signal in association with noxious stimulus (Fig. 4).
The mean time intervals from induction of anaesthesia
to intubation were 161 and 168 s for groups without and
with remifentanil, respectively (NS). The same ﬁgures for
intervals from anaesthetic induction to skin incision were
29 and 32 min, respectively (NS).
HR was similar in both groups, awake and 90 s after
induction of anaesthesia. From intubation to the end of the
study period, HR was higher in patients without remifenta-
nil (Fig. 1). The correlation between the change of HR
and that of RE2SE difference at endotracheal intubation
was poor: r¼0.179 (P¼0.336).
Rescue medication due to elevated SE values was
needed 18 times in 12 patients (nine in the propofol group
and three in the propofol–remifentanil group). None of
the patients, however, had recall, sore throat, or other com-
plaints in the postoperative interview.
Discussion
The ﬁrst ﬁnding in our study was that RE, SE, and
RE2SE difference increased in both groups during laryn-
goscopy and endotracheal intubation, along with continu-
ous EMG activity in the biosignal, in spite of remifentanil
(4.0 ng ml
21) in one group. The second ﬁnding was that
the intubation-associated increase in RE2SE difference
was only transient, because the increase in RE was often
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Fig 1 The behaviour of RE, SE, baseline-corrected RE2SE, and HR
[mean (SD)] during the study in patients receiving propofol–nitrous oxide
or propofol2nitrous oxide2remifentanil anaesthesia. 1, awake; 2, 90s after
anaesthetic induction; 3, 30s before intubation; 4, 30s after intubation; 5,
after a 5min equilibrium period; 6, 60s before skin incision; 7, 30s after
skin incision; 8, 30s after setting of the needle of Veress; 9, 30s after
beginning of gas insufﬂation; 10, at the end of gas insufﬂation; 11, 30s
after setting of the ﬁrst laparoscopy trochar.
’P,0.05,
’’P,0.01 within
the propofol–nitrous oxide group, respectively.
#P,0.05,
##P,0.01, and
*P,0.05, **P,0.01 within the propofol–nitrous oxide–remifentanil
group, and between the groups, respectively.
Table 1 Number of patients with small (,10), moderate (10 to  30) or large (.30 units) change in SE or RE values at intubation or skin incision. The mean
of three consecutive index values before intubation or skin incision is subtracted from that of three consecutive values 1 min after the event. *P¼0.006,
**P¼0.001 for SE and RE change values, respectively, between intubation and skin incision (two-tailed Mann–Whitney test)
Magnitude of
change in index values
Intubation*
, ** Incision
Propofol Propofol–remifentanil Propofol Propofol–remifentanil
SE RE SE RE SE RE SE RE
,10 units 7 4 8 7 9 9 16 15
10 to  30 units 4 7 6 5 5 5 0 1
.30 units 4 4 2 4 1 1 0 0
S 15 15 16 16 15 15 16 16
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230rapidly followed by an increase in SE. These ﬁndings
suggest that RE2SE difference cannot be used as a long-
lasting, reliable indicator of nociception. Although regu-
larly detected in the initial phase of stimulation, RE2SE
difference soon disappears due to increasing SE.
The small, though statistically signiﬁcant, difference in
RE2SE awake was most likely due to random factors,
11
because no abnormal EEG was seen in visual evaluation.
However, this difference in RE2SE awake was taken into
account by normalizing the groups in the way described in
Results. After baseline correction according to the awake
values, the RE2SE difference was higher in patients not
receiving remifentanil only at setting of the ﬁrst trochar.
The third ﬁnding was that intubation was associated
with greater increases in RE, SE, and RE2SE difference
than commencement of surgery. None of the indices
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Fig 2 (A) The appearance of EMG activity in EEG signal after
laryngoscopy (arrow downward) and attempted intubation in a patient not
receiving remifentanil. EEG signal remains suppressed, despite strong
EMG contamination. (B) Power spectrum of the EEG signal before (black
line) and after (grey line) laryngoscopy in the same situation as in (A).
EMG activity changes the spectrum after laryngoscopy. The spectrum
with EMG impact starts to change already below 20 Hz. Dotted vertical
line represents the 32 Hz frequency, which is used in Entropy calculation
to differentiate EEG activity (,32 Hz) from EMG activity (.32 Hz). In
Entropy calculation, low SE value increases rapidly after appearance of
EMG, because the power at ,32 Hz area increases. (C) EEG spectrogram
(frequency vs time) of the same patient as in (A) and (B). Fast activity
disappears in the beginning of anaesthesia (0–30 s). Continuous activity
below 30 Hz is merely EEG. Placement of oropharyngeal airway (OA) at
1 min 40 s elicits short EMG response, shown as a vertical bar up to 150
Hz. Laryngoscopy and attempted intubation (IA) at arrow is associated
with longer EMG response. Replacement of oropharyngeal airway at 3
min 50 s, and successful intubation (Intub) at 4 min 30 s. Long-lasting
EMG activity ensues.
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Fig 3 EEG spectrograms presenting the whole study periods in two
patients: (A) without and (B) with remifentanil infusion. Fast activity
disappears in the beginning of anaesthesia. EEG activity is seen in both
recordings as a continuous activity below 30 Hz. EMG contamination is
seen as vertical bars up to 150 Hz. AI, attempted intubation; I, intubation;
PP, patient positioning; SI, skin incision. Laryngoscopy and intubation
are associated with strong EMG activity in both recordings. Thereafter,
no EMG is seen in (B), that is, the patient receiving remifentanil. In (A),
both noxious and non-noxious stimuli (like positioning the patient) elicit
EMG activity. Horizontal bars at 50 and 150 Hz are power line (50 Hz)
artifacts and its harmonic (150 Hz). Vertical bars (ImpCh) indicate
automatic Entropy sensor impedance checks every 10 min.
Table 2 The occurrence of visible EMG in EEG signal along the course of study in patients receiving propofol–nitrous oxide or propofol–remifentanil–nitrous
oxide anaesthesia, and the association of EMG with RE–SE difference
Time point EMG present/absent (n) RE–SE [mean (SD)]
Propofol Propofol–remifentanil P-value (Fisher’s exact test) EMG present EMG absent P-value (t-test)
Awake 15/0 16/0 1.0 8.96 (1.70)
Inductionþ90 s 5/10 4/12 0.704 2.44 (2.35) 1.72 (1.83) 0.43
Before intubation 1/14 0/16 0.484 12 (0) 1.73 (1.86) ,0.001
After intubation 15/0 13/3 0.226 9.96 (7.6) 0.67 (0.33) ,0.001
Steady state 4/11 0/16 0.043 8 (1.63) 2.93 (3.6) 0.001
Before skin incision 2/13 0/16 0.226 12 (1.41) 2.52 (2.73) 0.027
After skin incision 6/9 0/16 0.007 12.17 (3.49) 1.96 (2.13) ,0.001
Needle of Veress 6/9 0/16 0.007 13 (6.48) 2.28 (3.01) 0.009
Start of gas insufﬂation 7/8 0/16 0.002 7.57 (5.16) 1.83 (2.44) 0.025
End of gas insufﬂation 8/7 0/16 0.001 8.38 (4.5) 1.52 (1.81) 0.003
Laparoscopy trochar 10/5 0/16 ,0.001 9.1 (2.92) 1.62 (1.96) ,0.001
EMG, RE, and SE during noxious stimuli
231showed increased values at skin incision. This is in line
with earlier literature, ranking endotracheal intubation as a
stronger nociceptive stimulus than skin incision.
12
The fourth and perhaps the most signiﬁcant ﬁnding was
that increased index values during nociceptive stimuli
were strongly associated with the presence of EMG, con-
ﬁrmed by visual analysis of the raw biosignal and by the
analysis of the spectrogram; both performed without
knowledge of anaesthesia regimen. Spectral analysis of the
biosignal demonstrated an EMG-associated change in the
spectrum at ,20–100 Hz.
After endotracheal intubation, no continuous EMG
activity in the raw signal, or signiﬁcant RE2SE difference
in Entropy values, was noted in patients receiving remifen-
tanil. EMG was more frequently present during surgical
manipulation in patients without remifentanil. The reactiv-
ity of upper facial biosignal was seen in nearly all patients
during intubation, in spite of lower RE and SE values than
was the case during commencement of surgery. This could
be explained by the high stimulus intensity of laryngo-
scopy and intubation
13 14 that elicits EMG activity also in
patients receiving remifentanil. Another postulation might
be the modelling of remifentanil pharmacokinetics: as the
estimated effect-site remifentanil concentration is based on
the cortical electrical activity,
10 it is theoretically possible
that the drug concentration was lower than assumed in the
areas controlling EMG. The EMG recorded is likely to be
both from facial- and trigeminal-innervated muscles as
the electrodes are on frontal and temporal muscles. The
pathways to frontal and temporal muscles are the facial
and trigeminal nerves, respectively, both originating from
the brain stem.
15 The Ke0 for remifentanil effect at the
brain stem might differ from that measured as a change in
EEG. The mean duration of 30 min from anaesthetic
induction to skin incision, on the other hand, was sufﬁ-
cient to complete the saturation of remifentanil, abolishing
the reactivity of EMG. Finally, as one of the electrodes
in the Entropy strip is placed on the patient’s temple, it is
possible that the EMG activity during laryngoscopy and
intubation comes partly from the temporal muscle, instead
of the frontal muscle. Further research is needed to eluci-
date the behaviour of EMG during intubation.
In analysis of Entropy and raw EEG signal, the presence
of EMG dictated Entropy values during nociceptive
events. Typically, RE values increased with short delay,
as described earlier by Vakkuri and colleagues.
6 In the
majority of cases, the increase of RE was soon followed
by an increase in SE values, decreasing the RE2SE differ-
ence. The increase in SE values was most probably due to
the increase in biosignal activity below 32 Hz, as depicted
in Figure 2. While all activity below 32 Hz is regarded
as EEG in the analysis of Entropy,
5 strong EMG impact
starts to change the spectrum already at 20 Hz.
16 This may
explain the unexpected behaviour of SE during nociceptive
stimuli, when anaesthesia regimen does not include ade-
quate anti-nociception or effective neuromuscular block.
Nociception-associated EMG activity may increase SE
values, because the content of the biosignal starts to
change already below 20 Hz (Fig. 2).
HR is a standard indicator of nociception. In this study,
HR differed between the groups from intubation to the end
of the study. Higher values were seen in patients without
remifentanil. This may indicate stronger nociceptive input
in these patients, although the direct effect of remifentanil
on HR should also be considered.
17 The poor correlation
between HR and RE2SE difference was most probably
due to the widespread nociception-elicited alterations in
EEG, reducing the RE2SE difference, as described above.
On the basis of our results, it is appropriate to conclude
that Entropy RE2SE difference may increase during strong
nociceptive stimuli, but this increase is often transient, due
to increasing SE values. Therefore, although high SE
values serve as an indicator of impending awareness, EMG
contamination can associate with high SE values during
otherwise sufﬁcient hypnotic state of anaesthesia. Adequate
anti-nociceptive medication, however, decreases the risk of
EMG contamination, as seen in our patients receiving
remifentanil.
One might argue that increasing SE levels in our study
indicate less adequate anaesthetic depth and impending
arousal. From a theoretical point of view, that is well
possible. However, the connection between EMG, spectral
characteristics of EEG, and SE was well demonstrated in
the present study. EMG is generated at brain stem level;
therefore, the presence of EMG is not a direct indicator of
awareness. Moreover, appearance of EMG does not
necessarily alter the underlying EEG signal during anaes-
thesia. As an example, in Figure 4, the burst suppression
EEG signal remained unaltered, although strong EMG
activity contaminated the signal. Finally, none of our
patients had recall despite high SE values, although the
study remains underpowered to examine awareness.
The biosignal was visually analysed by a single neuro-
physiologist with considerable experience on anaesthesia-
200 mV
+
–
4 s
40 s
Fig 4 Two successive 40 s samples of EEG which show development of
EMG after intubation (arrow upward) during EEG burst suppression. The
box below is an enlarged 4 s piece of the signal, showing the beginning
of EMG activity.
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232related EEG. No artifacts that could contribute signiﬁcantly
to the frequency bands above 32 Hz were detected in this
analysis. As shown in Figure 3, electrical noise appears as
a narrow band at 50 Hz, whereas electro-oculogram and
ECG artifacts are limited at low frequency areas, instead of
widespread EMG activity. With the aid of spectral presen-
tation, EMG is reliably detected in EEG.
The intraoperative EMG contamination of EEG is chal-
lenging for an anaesthetist, because such low-amplitude
activity is not always readily seen on monitor, even
though the displaying of ‘raw’ EEG signal is highly rec-
ommended. The EMG-associated increase in SE value
does not directly possess the risk of unintentional aware-
ness during anaesthesia, because high SE value usually
leads to re-adjustment of hypnotics. When remaining
undetected, the situation could, however, cause inappropri-
ate and potentially harmful use of anaesthetics.
The anaesthetic regimen of this study does not reﬂect our
routine clinical practice and necessitates a comment. Our
aim was to study the magnitude of RE2SE difference with
or without strong anti-nociceptive medication, and without
confounding impact of NMBAs. Nitrous oxide, however,
was used as a baseline anti-nociceptive agent in our intu-
bated patients under controlled ventilation. In most cases,
endotracheal intubation and commencement of surgery went
smoothly, whereas difﬁculties in intubation were faced in
two patients, who were discarded from the study. Owing to
the gentle manipulating techniques and used rescue medi-
cation, none of the patients reported any anaesthesia-related
sequelae. With this technique, we were able to demonstrate
the effects of EMG on the Entropy indices RE and,
especially, SE. As neuromuscular blockers were not used,
the impact of them remains to be studied later on.
In conclusion, we showed that Entropy RE2SE differ-
ence cannot reliably be used as an indicator of nociception
in patients anaesthetized with propofol, nitrous oxide, and
remifentanil without NMBAs. EMG activity can contami-
nate the interpretation, especially by increasing SE values.
Further research is needed to elucidate the effects of
EMG in detail, and to study the effect of neuromuscular
blocking agents on EMG signal.
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